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Abstract

Introduction

Background: To evaluate resident knowledge of colorectal cancer
(CRC) screening guidelines and to define areas requiring attention.

While the overall incidence of cancer has decreased during the years 2000-2006, colorectal cancer (CRC) remains
the third most common malignancy. It is the third leading
cause of cancer-related mortality among men and women
individually, and the second leading cause of cancer-related
mortality overall [1]. The incidence and mortality of CRC
have declined over the last 10 years with wider population
screening, but there is still room for improvement. A particular focus has been on the lower rates of screening for minority groups such as African Americans, already noted to have
higher rates of CRC-related mortality and poorer outcomes
[2].
Resident outpatient practices account for the primary
medical care of many underserved populations. Numerous
studies [3-7] have looked at the role of physicians-in-training
in health maintenance and screening. Ward et al performed
resident interviews to investigate what they felt were barriers
to screening for their own patients. While they were aware of
some of the beliefs and/or misconceptions within the community, they were unaware of many other recognized barriers to screening within the minority populations such as embarrassment related to the procedure and preparation, cost of
the procedure to the patient and access to care [7]. The provider turnover in a resident practice itself can compromise
effective health maintenance and screening. Identification of
a regular health care provider is a known positive correlate
for screening, but providers change every few years in the
resident practice. Some studies even estimate that as many as
50% of patients are lost to follow-up of their chronic medical
conditions and screenings when resident physicians graduate
and pass their patients on to new providers [8].
It is expected that as resident physicians advance in their
training, they become more educated regarding colon cancer
screening methods, and in turn more of their patients will
be appropriately screened. The data on this subject however
have been mixed. Gennarelli et al administered questionnaires to interns, residents and attending physicians with
the intention of assessing knowledge of the American College of Gastroenterology guidelines for CRC screening, and

Methods: A survey was created using three published guidelines
for CRC screening. Program directors for internal medicine residency programs were contacted within the metro New York City
area to have their residents participate.
Results: Five programs participated, and 115 responses were recorded. For the appropriate testing and interval to screen for CRC,
61/115 residents identified flexible sigmoidoscopy every 5 years,
108/115 identified colonoscopy every 10 years, 16/115 identified
double contrast barium enema (DCBE) every 5 years and only
12/115 thought CT-colography every 5 years was appropriate. Only
40/115 respondents appropriately identified fecal occult blood testing (FOBT) administered in the patient’s home annually, while fecal immunohistochemical testing (FIT) annually at home was identified by 8/115 residents.
Conclusion: While most residents seem knowledgeable regarding
CRC screening with colonoscopy, many deficiencies remain. FOBT
for screening purposes remains undervalued, and confusion about
administering the test persists. The distinction between screening
and prevention needs further reinforcement.
Keywords: Resident education; Colorectal cancer; Preventive
medicine
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Table 1. Number of Responders Correctly Identifying Appropriate Exams for Detection of CRC and Their Associated Intervals

Screening exam

PGY-1

PGY-2

PGY-3

P value

Flexible sigmoidoscopy every 5 years

29 (54.72%)

17 (53.13%)

15 (50.00%)

0.9179

Colonoscopy every 10 years

49 (92.45%)

31 (96.88%)

28 (93.33%)

0.7852

Virtual colonoscopy every 5 years

5 (9.43%)

3 (9.38%)

4 (13.33)

0.8332

Annual FOBT performed in the patient’s home

12 (22.64%)

12 (37.50%)

16 (53.33%)

*0.0174

Annual FIT performed in the patient’s home

3 (5.66%)

1 (3.13%)

1 (3.33%)

1.0000

Fecal DNA testing every 3 years

0 (0.00%)

1 (3.13%)

1 (3.33%)

0.2885

DCBE every 5 years

9 (16.98%)

2 (6.25%)

5 (16.67%)

0.3370

*Denotes a statistically significant value.

found that while overall knowledge was poor, it improved
by year of education [9]. Conversely, Wong et al measured
performance outcomes in multiple screening categories over
3 years of training, and found that actual patient screening
rates were similar across all years [10]. It is unclear if training regarding CRC screening is suboptimal, or if the guidelines themselves, which do not uniformly agree on appropriate screening ages, rates and modalities, may be partially to
blame [11-15]. The most recent guidelines also make a distinction between cancer detection and prevention. Prevention in this context means a test with the potential to detect
adenomatous polyps, the removal of which has been shown
to decrease the risk of future malignancies [16]. This terminology is appropriate, but may add an additional element of
confusion. The purpose of our study was to evaluate knowledge of CRC screening methods across 3 years of internal
medicine training, to demonstrate if knowledge of screening
improves with advancing post-graduate year (PGY) level,
and to identify specific targets areas for training improvement.

Methods
An 11-question survey was created in November 2010 using
three of the more well-known published guidelines for CRC
screening (ACG, USPSTF and ACS guidelines [11, 15, 17,
18]) and uploaded to a survey manager website (www.kwiksurveys.com) to be accessed anonymously in order to mitigate any potential bias. The ASGE guidelines were not included into the creation of our survey, as they focused more
on colonoscopy and sigmoidoscopy, and did not make many

recommendations regarding alternative screening methods.
The ACP (American College of Physicians) drafted a guideline statement [17] subsequent to the administration of our
survey, but much of their statement was derived from the
same sources as our survey. The first question simply asked
for the year of training, in order to create a subset for analysis
by year of training. Respondents had the ability to answer
with multiple correct choices for each subsequent question,
reflecting the multiple options presented in the source guidelines. A copy of the survey form has been made available as
an addendum to this manuscript.
Program directors for internal medicine residency programs at academic institutions were contacted within the
metro New York City area, and asked to have their residents
participate anonymously in the survey. Five programs agreed
to participate, and 676 invitations were offered to their residents from December 2010 to January 2011. There were 115
responses, for a response rate of 17% (Fig. 1). All responses
were anonymous and confidential, identified only by an I.P.
address, and viewable only by the investigators. All responses were tabulated into a Microsoft Excel sheet and data were
evaluated initially in aggregate, and then compared by PGY
of training. All analyses were conducted using SAS version
9.3 (Cary, NC). The study was approved by the Institutional
Review Board of the North Shore Long Island Jewish Health
System.

Results
The data were initially analyzed in aggregate, followed by a
subset analysis. Of the 115 respondents, there were 53 PGY-
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*0.0756
12 (22.64%)
For patients with a first degree relative with CRC > age 60, or two second degree relatives
with CRC begin at age 50^

*Denotes a statistically significant value. ^Appropriate answer as per ACG 2008 guidelines. ^^Appropriate answer as per ACS 2008 guidelines.

14 (46.67%)

3 (5.66%)
For patients with a first degree relative with CRC > age 60, or two second degree relatives
with CRC begin at age 40^^

11 (34.38%)

0.7383
3 (10.00%)

34 (64.15%)
For patients with a first degree relative with CRC < age 60 begin at age 40 or 10 years
younger than the index case

3 (9.38%)

0.6141
22 (73.33%)

11 (20.75%)
For average risk African-American patients begin at age 45

20 (62.50%)

0.3460
4 (13.33%)

52 (98.11%)
For average risk patients begin at age 50

3 (9.38%)

1.000
29 (96.67%)

PGY-1

31 (96.88%)

J Clin Med Res. 2014;6(2):120-126

When to begin screening?

Table 2. Responses to Appropriate Age to Begin Screening for CRC in Various Populations

PGY-2

PGY-3

P value

Colorectal Cancer Screening

1 residents, 32 PGY-2 residents and 30 PGY-3 residents.
When polled regarding the appropriate testing and interval to
screen for CRC, 61/115 residents identified flexible sigmoidoscopy every 5 years, 108/115 identified colonoscopy every
10 years, 16/115 identified double contrast barium enema
(DCBE) every 5 years as an acceptable modality and interval
and only 12/115 thought CT-colography (i.e. virtual colonoscopy) every 5 years was appropriate. When questioned regarding alternative methods, only 40/115 appropriately identified fecal occult blood testing (FOBT) administered in the
patient’s home annually while fecal immunohistochemical
testing (FIT) annually at home was identified by 8/115 residents. Fecal DNA testing was considered an option by only 7
residents, with 2 out of 7 agreeing with testing every 3 years,
and the remaining 5 recommending an annual examination.
The questions were also readdressed for CRC prevention rather than screening/detection. Only 73/115 thought
colonoscopy every 10 years was appropriate for cancer prevention, 44/115 flexible sigmoidoscopy every 5 years and
6/115 thought flexible sigmoidoscopy every 10 years was
appropriate. Few respondents (10/115) found DCBE every 5
years to be appropriate, with a slightly larger number of respondents (15/115) identifying CT colography every 5 years.
There were significantly fewer responses for FOBT, FIT and
fecal DNA, but 18/115 incorrectly identified annual FOBT
in the home, and 21/115 incorrectly identified annual office
FOBT as viable options for CRC prevention.
Subset analysis also compared individuals based on their
PGY of training (Table 1). All answers were compared using
Chi-squared analysis, unless there were too few responses in
any one instance, in which case Fisher’s exact testing was
calculated. There was not a statistically significant difference
in knowledge by year of training, except for annual home
FOBT as a CRC detection test.
Nearly all (112/115) of those polled were aware that
50 years of age is considered the appropriate time to begin
screening for CRC in average risk adults, but only 18/115
recommended screening of average risk African Americans
beginning at age 45, as mentioned in the current ACG practice guidelines [19]. For patients with first degree relatives
with CRC before age 60, 76/115 respondents appropriately
identified age 40 or 10 years younger than the index case as
the appropriate time to begin screening for CRC.
For patients with first degree relatives diagnosed with
CRC after age 60, or with multiple second degree relatives,
responses varied. Forty out of 115 residents answered that
50 is an appropriate age to begin, no different than average
risk screening, which is consistent with the ACG guidelines.
Nine out of 115 respondents thought 40 years of age would
be an appropriate age to begin screening, which is recommended by the current joint American Cancer Society/US
Multi-Society Task Force/American College of Radiology
guidelines.
Nearly all (114/115) respondents appropriately identi-
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Table 3. Initiation of Screening - Comparison of the Guidelines (ACS/USPSTF/ACG/ASGE)

When to begin screening?

ACS

USPSTF

ACG

ASGE

For average risk patients

Begin at age 50

Begin at age
50

Begin at age 50

Begin at age 50

For average risk African-American
patients

Begin at age 45

Not addressed

Not addressed

Not addressed

For patients with a first degree
relative with CRC < age 60

Begin at age 40 or 10
years younger than
the index case

Not addressed

Begin at age 40 or 10
years younger than the
index case

Begin at age 40 or 10
years younger than the
index case

For patients with a first degree
relative with CRC > age 60, or
two second degree relatives with
CRC

Begin at age 40

Not addressed

Begin at age 50
(same as average risk
screening)

Begin at age 40

*Our study concept was designed with the ACS/USPSTF/ACG guidelines. The ASGE guidelines are provided for further comparison.

fied colonoscopy as a valid screening test for patients with
first degree relatives with CRC before age 60. However,
33/115 incorrectly chose flexible sigmoidoscopy, 32/115
FOBT, 17/115 CT colography, 5/115 FIT, 5/115 fecal DNA
and 7/115 DCBE.
Subset analysis of appropriate ages to begin screening
in the various populations, evaluated by PGY of training can
be found in Table 2.

Discussion
While meant to guide, standardize, and simplify population
wide colon cancer screening, the current, multiple guidelines themselves may be a source of confusion for healthcare providers, especially for those in training. While basic
principles of the guidelines, such as screening at age 50 for
average risk patients, are relatively uniform among all the
guidelines, some of the other recommendations are conflicting (Table 3). For example, in regard to a patient with a first
degree relative diagnosed with CRC after age 60 or two
second degree relatives with CRC, the guidelines differ in
their recommendations for the age to begin screening. The
most recent ACG guidelines [11] recommend screening at
the default age of 50, but the most recent American Cancer
Society guidelines [15] advocate more aggressive screening
by beginning at age 40.
A national survey performed by Oxentenko et al [20]
sought to evaluate how confident and prepared residents
within primary care programs felt in regard to CRC guidelines and recommendation. Most of the residents polled

responded that they were somewhat comfortable with the
guidelines and their implementation, and their level of comfort seemed to increase by PGY. Our survey findings suggest
that this comfort may be misplaced. The findings were favorable in regard to screening colonoscopy in most average
risk individuals, but knowledge of other methods was more
disparate, and did not improve with advancing years of education within the programs. Similarly a study published in
2005 sought to compare screening rates for patients of PGY1
and PGY2 residents for multiple preventative healthcare areas including CRC, to evaluate if “seniority” was a factor
for improvement [21]. The authors found that there was no
statistically significant difference in the screening rates between both years of training.
While our study was performed specifically in internal
medicine residencies, it did not distinguish between those
residents who were training under a traditional “categorical”
track or those training in a “primary care” - focused track. An
et al differentiated between the two groups when they evaluated performance for preventive screening tests in breast,
cervical and colorectal cancers. The authors found that year
of training did not seem to improve screening rates, nor did
a specific primary care focus in the residents’ training [6].
Two points of particular interest become clear when reviewing the results of our study. First, there appears to be
significant confusion among the resident physicians between
the concepts of cancer detection and cancer prevention. The
guidelines themselves lend to this confusion, as only the
ACG and the ACS/US Multi-Society Task Force guidelines
acknowledge differences in regard to patient testing; the
ASGE guidelines do not. The US Preventive Services Task
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*Our study concept was designed with the ACS/USPSTF/ACG guidelines. The ASGE guidelines are provided for further comparison.

Not recommended
Every 3 years
Interval uncertain
Fecal DNA

No recommendation given

No recommendation given
Annually
Annually
FIT

Annually

Annually
Annually
Annually
FOBT

Annually

Not recommended
Every 5 years
Every 5 years
Virtual colonography

No recommendation given

Not recommended, but if used,
perform every 5 years
No recommendation given
Every 5 years

No recommendation given

J Clin Med Res. 2014;6(2):120-126

DCBE

Every 10 years
Every 10 years
Every 10 years
Colonoscopy

Every 10 years

Every 5 years
Every 5 - 10 years
Not recommended
Every 5 years
Flexible sigmoidoscopy

USPSTF
ACS

Table 4. Screening Interval Comparison by Modality (ACS/USPSTF/ACG/ASGE)

ACG

ASGE

Colorectal Cancer Screening

Force (USPSTF) omits any distinction between detection
and prevention, while recommending certain tests such as
colonoscopy, sigmoidoscopy and FOBT, and rejecting others such as fecal DNA or CT colography found in the other
guidelines [18].
The second point highlighted by the survey is that alternative means for cancer detection beyond colonoscopy and
sigmoidoscopy need to be better stressed during the education of our residents. This again is not uniformly agreed upon
by the various guidelines (Table 4). There was an inadequate
level of knowledge demonstrated by the respondents, with
no improvement in knowledge by year, regarding any of the
alternative screening modalities with the exception of annual
home-administered FOBT. There was statistically significant improvement by year in regard to correct administration of FOBT, but still low recognition overall. There was a
low recognition of the value of stool genetic testing and CT
colography, but these may be deficient for the simple reason
that neither is currently a routinely covered service by third
party payers or Medicaid. This is certainly not the case however for an annual FOBT. We suspect that the strong current
emphasis on colonoscopy-based screening may come at the
expense of developing the knowledge and expertise for other
modalities such as standard, proven FOBT. Residents may
learn about the alternatives to colonoscopy from their textbooks, but only experience the alternatives in limited clinical
practice.
While the rates of screening colonoscopies have increased in the last few years, there still remain patients who
do not wish to have colonoscopies performed as a first-line
examination due to the invasive nature of the test, as well as
the preparation for the exam. Also, while the residents were
surveyed in a community with ample access to colonoscopy
services, many geographic regions lack this access. We need
to better educate our providers so that they will be equipped
to offer alternatives to colonoscopy when necessary, and
therefore continue to increase the rate of screening among
their patients.
While our focus has been upon improving physician education, we acknowledge that other solutions to improve CRC
screening rates exist. Lane et al [22] showed that in a large
county health center, continuing education initiatives with
providers and their staff can increase internal completion
rates for CRC screening, both for FOBT and colonoscopy.
It is worth highlighting that the authors chose a two-pronged
approach (administering an evidence-based lecture and applying a clinical prompt) to increase awareness and education regarding CRC screening. Education alone does not
seem to be an adequate method to improve screening rates.
Seres et al [23] evaluated two comparison initiatives at the
provider level to improve the quality of care in CRC screening: an evidence-based lecture regarding screening guidelines, compared to the lecture in addition to a written prompt
on the patient chart for all applicable patients. The study
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found that clinical prompts significantly improved completion of CRC screenings among physician providers when
compared to administering evidence-based lectures alone.
Another study performed by Schroy et al [24] compared the
utility of providing screening education for resident physicians using didactic lectures in comparison to didactic lectures in combination with an interactive case-based model.
They found that while there was a small, statistically significant improvement in screening rates for those residents who
received both educational interventions, the authors felt that
it still had limited influence on clinical risk assessment skills.
These studies imply that while education is a valuable tool,
there may be a need for additional interventions to improve
screening performance.
Conclusion
While most residents seem knowledgeable regarding CRC
screening with colonoscopy and the proper screening age for
average risk individuals, many deficiencies remain. FOBT
for screening purposes remains undervalued, and confusion
about properly administering the test persists. The distinction
between screening and prevention, addressed in the ACG
and US Multi-Society Task Force guidelines but absent from
the USPSTF recommendations, needs further reinforcement.
For patients with a high risk family history, there appears to
be a knowledge deficit, though the discrepancies between the
different guidelines may themselves contribute to the confusion. Based on our results we conclude that the education of
medical residents regarding CRC screening and prevention
guidelines is deficient, and we have identified clear and vital
target areas for further reinforcement.
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